Contineum Therapeutics Inc-a (CTNM) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

CTNM ranks #4503 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CTNM is a top-conviction position for Sectoral Asset Management Inc — at 8.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CTNM belongs to Montanova Capital, LLC, but the position matters far more to Sectoral Asset Management Inc, who has 8.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

BlackRock has added to its CTNM position for two straight quarters, increasing it by $27.7M to reach $33.8M today.

Steve Cohen has trimmed its CTNM position for two straight quarters, cutting it by $8.3M while still holding $422.5K.

CTNM is up 4.2% today, and institutions have been net buyers of $63.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

CTNM reported a net loss of $57.6M over the trailing twelve months.

• Not yet profitable — net loss of $57.6M over the trailing twelve months
• Net income declined year over year, from -$56.9M to -$57.6M
• Operating cash flow was negative, using $55.3M in cash
• Current ratio of 27.50x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.06x equity — within a conventional range